Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Journal of Oncology Pharmacy Practice

A new frontier in oncology: Understanding the landscape of cancer vaccines

View Full Paper
Ask AI
Bookmark
Share

Authors

TSTarun Kumar SuvvariKKKeshavi KilliSVShreya Veggalam

Discussion

Loading...

Member takes

Overview

This review uncovers mechanisms of cancer vaccines, highlighting their role in improving immune responses and addressing barriers.

Key Points

  • Cancer vaccines aim to improve patient outcomes by training the immune system to recognize tumor antigens, and they represent a promising approach in oncology.
  • Prophylactic vaccines like HPV have reduced virus-related cancers, while therapeutic vaccines like Sipuleucel-T have improved survival rates in cancer patients.
  • Innovative platforms such as mRNA, peptide, and viral vectors are being developed, showcasing their efficacy in clinical trials despite challenges in tumor immune evasion.
  • Ongoing challenges in neoantigen selection and global disparities in vaccine access call for enhanced collaboration and infrastructure to maximize benefits.

Cite This Study

Suvvari et al. (2025) studied this question.

synapsesocial.com/papers/68c23cf6b210217d6478c166https://doi.org/10.1177/10781552251375363
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer Vaccines: A Brief Overview2025
  2. 2Comparison of Current Immunotherapy Approaches and Novel Anti-Cancer Vaccine Modalities for Clinical Application2025 · 5 citations
  3. 3Neoantigen-driven cancer vaccines: Revolutionizing precision oncology through personalized immunotherapy2025 · 1 citations
  4. 4Mapping the cancer vaccine landscape.2025
  5. 5Therapeutic Cancer Vaccines in Colorectal Cancer: Platforms, Mechanisms, and Combinations2025